Why the study?
Do calcium entry blockers reduce blood pressure and improve abnormal vasomotion in patients with hypertension?
Population
Patients with hypertension and other cardiovascular disorders
Design
Review
Authors
Loading...
Mechanistic support for calcium entry blockers in hypertension; leaves open prospective validation of effects on abnormal vasomotion.
Do calcium entry blockers reduce blood pressure and improve abnormal vasomotion in patients with hypertension?
Calcium entry blockers provide a mechanistic approach to treating hypertension by interfering with cellular mechanisms for vasoconstriction.
Jay N. Cohn (1983) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: